Open-label Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy
Clinical trial NCT06484868 · RECRUITING
Trial details
- NCT number
- NCT06484868
- Sponsor
- Amryt Pharma
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-08
- Primary completion
- 2028-02-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.